MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    White Matter Perivascular Spaces in Parkinson’s Disease are Associated with Decreased Cognition, Interrupted Sleep, and Less Physical Activity

    E. Donahue, S. Venkadesh, R. Foreman, J. Duran, V. Bui, D. Wing, A. Petkus, I. Litvan, E. Bayram, D. Schiehser, J. Choupan, M. Jakowec, G. Petzinger (Los Angeles, USA)

    Objective: To determine the association of Perivascular Spaces (PVS) and non-motor features in Parkinson’s disease (PD). Background: PVS are the fluid-filled spaces surrounding blood vessels…
  • 2022 International Congress

    Pronunciation characteristics of patients with Parkinson’s disease based on sustained vowel speech

    Y. Wen, X. Zou (Chengdu, China)

    Objective: This study attempted to objectively analyze the acoustic characteristics of PD by using dynamic laryngoscope DIVAS2.5 acoustic analysis system and Praat acoustic software, and provide…
  • 2022 International Congress

    PLA2G6-related dystonia-parkinsonism in identical twins manifesting at an advanced age: a case report and review of the literature.

    D. Sugar, K. Kompoliti (Chicago, USA)

    Objective: To report a rare presentation of a rare disease and illustrate the range of phenotype seen in PLA2G6-associated dystonia-parkinsonism (PLADP). Background: PLA2G6 encodes a…
  • 2022 International Congress

    Sex differences in vascular risk factors for Parkinson’s disease

    K. Tsutsumi, E. Shah, A. Siddiqui, I. Attaripour (Orange, USA)

    Objective: Our aim is to illustrate the incidence of vascular risk factors (VRF) in a cohort of patients with confirmed Parkinson's disease (PD) and characterize…
  • 2022 International Congress

    Priorities of PD patients for treatment of cognitive-driven ADL impairment

    I. Liepelt-Scarfone, M. Bentele, S. Becker, C. Altmann, E. Schaeffer, K. Michaelis, S. Solbrig, K. Brockmann (Tübingen, Germany)

    Objective: To define cognitive-driven impairments in activities of daily living (ADL) with high priority for rehabilitation ranked by Parkinson’s disease (PD) patients. Background: Impairments in…
  • 2022 International Congress

    Gait under unsupervised, but not supervised conditions, differentiates between Parkinson disease with and without fatigue

    A. Rizzardi, A. Pilotto, C. Hansen, C. Zatti, G. Bonzi, R. Romijnders, W. Maetzler, A. Padovani (Brescia, Italy)

    Objective: To Assess the impact of fatigue on gait in Parkinson Disease patients in different evaluation conditions. Background: Fatigue is a common and disabling symptom…
  • 2022 International Congress

    Improving timely administration of PD meds in the hospital by using “custom” schedules

    H. Azmi, F. Ruzicka, L. Cocoziello, J. Pederson, E. Clar, A. Rocco, F. Thomas (Oradell, USA)

    Objective: To determine if there are differences in timely administration of medications in hospitalized patients with Parkinson’s Disease (PD) when orders are placed for a…
  • 2022 International Congress

    Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

    S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

    Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
  • 2022 International Congress

    Nigral microvasculature imaging in Parkinson’s disease

    S. Sharma, S. Buch, D. Reese, M. Haacke, M. Jog (London, Canada)

    Objective: The goal of this work is to image the microvasculature of the midbrain, in particular the substantia nigra in Parkinson’s disease (PD) patients using…
  • 2022 International Congress

    Pilot study of narrative medicine (NM) interventions in facilitating advance care planning (ACP) in Parkinson’s disease (PD): a feasibility study

    J. Jiao, B. Lobb, A. Hiller (Portland, USA)

    Objective: To demonstrate the feasibility of conducting NM interventions in PD and to describe NM’s potential impact upon ACP. Background: ACP is associated with increased…
  • « Previous Page
  • 1
  • …
  • 325
  • 326
  • 327
  • 328
  • 329
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley